Review Committee on the Functioning of the International Health Regulations (2005) during the COVID-19 Response
World Health Assembly resolution WHA73.1 requested the WHO Director-General, inter alia, to initiate a stepwise process of impartial, independent and comprehensive
evaluation of the WHO-coordinated international health response to COVID-19, including by using existing mechanisms such as the Review Committee under the International Health Regulations (2005) (IHR).
In line with the resolution, the WHO Director-General has convened a Review Committee under the IHR:
- to review the functioning of the IHR during the COVID-19 response; and
- the status of implementation of the relevant recommendations of previous IHR Review Committees.
The Committee begins its work on 8 and 9 September 2020 and will meet regularly and report on its progress, through the Director-General, to WHO Governing Bodies.
Reports
Report of the Review Committee on the Functioning of the International Health Regulations (2005) during the COVID-19 response
Interim progress report of the Review Committee on the functioning of the IHR (2005) during the COVID-19 response
Third meeting of the review committee on the functioning of the International Health Regulations (2005) during the COVID-19 response
Second meeting of the review committee on the functioning of the International Health Regulations (2005) during the COVID-19 response
First meeting of the review committee on the functioning of the International Health Regulations (2005) during the COVID-19 response
Statements
Members
Director of Surveillance, Area of Infection Control, Management and Staff, Norwegian Institute of Public Health, Norway
Director of Center of Epidemiology and Health Policy, Faculty of Medicine at Universidad del Desarrollo, Chile
Director General for Disease Surveillance and Control at the Ministry of Health of Oman
Colonel (retired) Vincent Anami
Continent Representative (Africa), Center for Disaster and Humanitarian Assistance Medicine, Uniformed Services University of the Health and Sciences, Friends International Centre, Nairobi, Kenya
Dr Thouraya Annabi Attia
Former Director of the Food Safety Department at The National Agency of Sanitary and Environmental Control of Products, Ministry of Health, Tunisia
Director of Health and Social Policy, Delegation of the Spanish Government in Catalonia, Spain
Ms Malinee Chittaganpitch
Medical Scientist Advisor, Department of Medical Sciences, MoPH Thailand
Professor James LeDuc
Director, Galveston National Laboratory, University of Texas Medical Branch, United States of America
Dr Dexin Li
Former Director, National Institute for Viral Diseases Control and Prevention, Chinese Center for Disease Control and Prevention, People’s Republic of China
Director General, Federal Budgetary Research Institution
Dr Talat Mokhtari Azad
Director, Iranian National Influenza Center, Department, Tehran University of Medical Sciences, School of Public Health, Tehran, Islamic Republic of Iran
Chief Medical Officer at Casablanca International Airport, Morocco; National Coordinator of the Points of Entry Program of Morocco
Ms Olubunmi Ojo
Former Director, Surveillance and Epidemiology and responsible for implementation of International Health Regulations at the National Public Health Institute, Nigeria
Public health consultant, Kinshasa, Democratic Republic of the Congo Former director of the vaccines and immunization department, WHO Headquarters, Geneva, Switzerland (Retired)
Director, Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, Japan
Dr Mark Salter
Consultant in Global Health, Public Health England, London, United Kingdom of Great Britain and Northern Ireland
Professor Myongsei Sohn
Professor Emeritus, College of Medicine, Yonsei University, Republic of Korea